Samuel a. Wickline

Q: What Schools Are Affiliated With Samuel a. Wickline

Samuel a. Wickline is affiliated with the following schools: Ohio State University, University of Michigan, Harvey Mudd College, University of Missouri, University of South Florida, Baylor College of Medicine, University of Texas Health Science Center at Houston, University of Pennsylvania

Samuel a. Wickline's AcademicInfluence.com Rankings

Samuel a. Wickline

Biology

#8273

World Rank

#11323

Historical Rank

Cell Biology

#319

World Rank

#327

Historical Rank

Immunology

#466

World Rank

#483

Historical Rank

Molecular Biology

#1034

World Rank

#1058

Historical Rank

biology Degrees

Download Badge

Biology

Samuel a. Wickline's Degrees

Masters Molecular Biology Stanford University

Why Is Samuel a. Wickline Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Samuel a. Wickline's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. (2011) (851)
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles (2003) (635)
Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques (2001) (535)
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. (1997) (492)
Nanotechnological applications in medicine. (2007) (422)
A novel site-targeted ultrasonic contrast agent with broad biomedical application. (1996) (400)
Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. (1996) (375)
Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging (2003) (348)
Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. (2003) (346)
Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis (2006) (333)
Novel real‐time R‐wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions (1999) (329)
Practical Value of Cardiac Magnetic Resonance Imaging for Clinical Quantification of Aortic Valve Stenosis: Comparison With Echocardiography (2003) (300)
Manganese-based MRI contrast agents: past, present and future. (2011) (290)
Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis (2002) (276)
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI (2004) (264)
Paracrine induction of endothelium by tumor exosomes (2009) (262)
Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles (2000) (251)
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. (2009) (242)
High‐resolution MRI characterization of human thrombus using a novel fibrin‐targeted paramagnetic nanoparticle contrast agent (2000) (233)
Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles (2005) (232)
Remodeling of cardiac fiber structure after infarction in rats quantified with diffusion tensor MRI. (2003) (226)
Maximizing exosome colloidal stability following electroporation. (2014) (219)
Regional ventricular wall thickening reflects changes in cardiac fiber and sheet structure during contraction: quantification with diffusion tensor MRI. (2005) (215)
Nanotechnology for molecular imaging and targeted therapy. (2003) (215)
RNA interference knockdown of DNA methyl-transferase 3 affects gene alternative splicing in the honey bee (2013) (211)
Targeted ultrasonic contrast agents for molecular imaging and therapy. (2001) (203)
Targeted contrast agents for magnetic resonance imaging and ultrasound. (2005) (200)
Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients. (1989) (198)
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles (2007) (195)
Improved molecular imaging contrast agent for detection of human thrombus (2003) (193)
Quantification of in‐plane motion of the coronary arteries during the cardiac cycle: Implications for acquisition window duration for MR flow quantification (1998) (192)
Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. (2000) (187)
Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles (2004) (184)
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. (2006) (180)
A relationship between ultrasonic integrated backscatter and myocardial contractile function. (1985) (174)
The dependence of myocardial ultrasonic integrated backscatter on contractile performance. (1985) (170)
Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. (2008) (170)
Sensitive detection of the effects of reperfusion on myocardium by ultrasonic tissue characterization with integrated backscatter. (1986) (167)
Revisiting an old friend: manganese-based MRI contrast agents. (2011) (163)
Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics (2009) (161)
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. (2003) (159)
Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. (2010) (158)
Molecular photoacoustic imaging of angiogenesis with integrin‐targeted gold nanobeacons (2011) (155)
Computed tomography in color: NanoK-enhanced spectral CT molecular imaging. (2010) (152)
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. (2008) (150)
In vivo “hot spot” MR imaging of neural stem cells using fluorinated nanoparticles (2008) (148)
Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology (2005) (142)
A review of exosome separation techniques and characterization of B16-F10 mouse melanoma exosomes with AF4-UV-MALS-DLS-TEM (2014) (136)
Magnetic resonance molecular imaging with nanoparticles (2004) (136)
Magnetic resonance imaging of melanoma exosomes in lymph nodes (2015) (134)
Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. (2006) (131)
Occult Cardiac Contractile Dysfunction in Dystrophin-Deficient Children Revealed by Cardiac Magnetic Resonance Strain Imaging (2005) (125)
Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. (2008) (121)
Performance of QRS detection for cardiac magnetic resonance imaging with a novel vectorcardiographic triggering method (2000) (118)
Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles (2007) (115)
Contrast agents for MRI (2008) (114)
Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model (2008) (113)
Resolution of Established Cardiac Hypertrophy and Fibrosis and Prevention of Systolic Dysfunction in a Transgenic Rabbit Model of Human Cardiomyopathy Through Thiol-Sensitive Mechanisms (2009) (113)
Ultrasound integrated backscatter tissue characterization of remote myocardial infarction in human subjects. (1989) (112)
An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging. (2012) (109)
Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies. (2008) (108)
In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. (2000) (108)
Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. (1989) (105)
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics (2007) (103)
Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. (1997) (101)
In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. (1998) (100)
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. (2008) (100)
Molecular photoacoustic tomography with colloidal nanobeacons. (2009) (100)
Minute dosages of ανβ3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits (2008) (99)
In Vitro Demonstration Using 19F Magnetic Resonance to Augment Molecular Imaging With Paramagnetic Perfluorocarbon Nanoparticles at 1.5 Tesla (2006) (97)
Quantitative magnetic resonance fluorine imaging: today and tomorrow. (2010) (95)
Structural Remodeling of Human Myocardial Tissue After Infarction: Quantification With Ultrasonic Backscatter (1992) (95)
Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. (2007) (94)
Cytolytic Nanoparticles Attenuate HIV-1 Infectivity (2013) (94)
Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury (2016) (94)
Intramural Delivery of Rapamycin With &agr;v&bgr;3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury (2008) (93)
Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles. (2012) (93)
Targeted PARACEST nanoparticle contrast agent for the detection of fibrin (2006) (93)
Stress cardiovascular magnetic resonance: consensus panel report. (2001) (92)
Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. (2000) (92)
Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. (2000) (90)
High-frequency ultrasonic detection of thrombi with a targeted contrast system. (1997) (89)
Nanomedicine: perspective and promises with ligand-directed molecular imaging. (2009) (89)
Gadolinium‐modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging (2008) (89)
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy. (2011) (88)
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions (2010) (86)
Conquering the dark side: colloidal iron oxide nanoparticles. (2009) (86)
Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis (2011) (86)
Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. (1998) (85)
Nanomedicine strategies for molecular targets with MRI and optical imaging. (2010) (84)
High Sensitivity: High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model (2009) (83)
Blood pool agent strongly improves 3D magnetic resonance coronary angiography using an inversion pre‐pulse (1999) (83)
Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. (2009) (80)
Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles. (2004) (79)
αvβ3–Targeted nanotherapy suppresses inflammatory arthritis in mice (2009) (78)
The extracellular matrix is an important source of ultrasound backscatter from myocardium. (2000) (78)
Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery. (2005) (77)
Molecular imaging, targeted therapeutics, and nanoscience (2002) (77)
Colloidal hollow spheres of conducting polymers with smooth surface and uniform, controllable sizes. (2009) (75)
A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results. (2004) (75)
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. (2013) (75)
NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. (2017) (74)
Successful performance of Cox-Maze procedure on beating heart using bipolar radiofrequency ablation: a feasibility study in animals. (2004) (74)
Ultrasonic determination of the anisotropy of Young's modulus of fixed tendon and fixed myocardium. (1996) (73)
Quantitative real-time imaging of myocardium based on ultrasonic integrated backscatter (1989) (73)
Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. (2014) (72)
Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. (2003) (71)
Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. (2006) (71)
MR tagging demonstrates quantitative differences in regional ventricular wall motion in mice, rats, and men. (2006) (71)
1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. (2005) (70)
Echocardiographic characterization of fundamental mechanisms of abnormal diastolic filling in diabetic rats with a parameterized diastolic filling formalism. (2001) (70)
A proposed microscopic elastic wave theory for ultrasonic backscatter from myocardial tissue. (1995) (69)
A systematic approach to exosome-based translational nanomedicine. (2012) (69)
Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide (2014) (68)
Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. (2004) (68)
Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model (2002) (68)
Three-dimensional characterization of human ventricular myofiber architecture by ultrasonic backscatter. (1991) (68)
Melittin derived peptides for nanoparticle based siRNA transfection. (2013) (67)
Emerging nanomedicine opportunities with perfluorocarbon nanoparticles (2007) (66)
Simultaneous dual‐nuclei imaging for motion corrected detection and quantification of 19F imaging agents (2011) (65)
Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. (2007) (65)
A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. (2011) (63)
Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS (2008) (63)
Progress in quantitative ultrasonic characterization of myocardium: from the laboratory to the bedside. (1988) (61)
Harmonic phase MR tagging for direct quantification of lagrangian strain in rat hearts after myocardial infarction (2004) (60)
Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces* (2010) (60)
Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. (2009) (59)
A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin. (2015) (59)
Differentiation between acutely ischemic myocardium and zones of completed infarction in dogs on the basis of frequency-dependent backscatter. (1989) (58)
Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. (2009) (58)
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging (2008) (58)
Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. (1995) (58)
Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles (2010) (58)
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function (2014) (58)
Enhanced Transmural Fiber Rotation and Connexin 43 Heterogeneity Are Associated With an Increased Upper Limit of Vulnerability in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy (2007) (57)
Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles. (2012) (55)
Targeted ultrasonic contrast agents for molecular imaging and therapy. (2003) (55)
Platelet trapping in myocardial infarct in baboons: therapeutic effect of aspirin. (1980) (55)
Comparison of the anisotropy of apparent integrated ultrasonic backscatter from fixed human tendon and fixed human myocardium. (1995) (54)
Programmable nanoparticle functionalization for in vivo targeting (2013) (54)
Anisotropy of ultrasonic velocity and elastic properties in normal human myocardium. (1992) (54)
Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles. (2007) (54)
A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions (2019) (53)
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. (2010) (53)
Recent advances in colloidal gold nanobeacons for molecular photoacoustic imaging. (2011) (52)
Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo (2006) (52)
A Real-Time Integrated Backscatter Measurement System for Quantitative Cardiac Tissue Characterization (1986) (52)
Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging. (2007) (52)
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. (2011) (51)
Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis. (2009) (50)
Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. (2004) (49)
Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging. (2005) (48)
In vivo quantification of T1, T2, and apparent diffusion coefficient in the mouse retina at 11.74T (2008) (48)
Detection of Unique Transmural Architecture of Human Idiopathic Cardiomyopathy by Ultrasonic Tissue Characterization (1992) (48)
Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions (2015) (46)
Inhibition of thrombin attenuates stenosis after arterial injury in minipigs. (1996) (46)
Effect of collagen on the anisotropy of quasi-longitudinal mode ultrasonic velocity in fibrous soft tissues: a comparison of fixed tendon and fixed myocardium. (1994) (45)
A facile synthesis of novel self-assembled gold nanorods designed for near-infrared imaging. (2010) (44)
Quantification of ultrasonic anisotropy in normal myocardium with lateral gain compensation of two-dimensional integrated backscatter images. (1993) (44)
Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents. (2015) (43)
Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice (2017) (43)
Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus. (2011) (43)
Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy (2005) (42)
Improved Paramagnetic Chelate for Molecular Imaging with MRI (2005) (42)
Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. (2007) (41)
Temperature dependence of acoustic impedance for specific fluorocarbon liquids. (2002) (41)
Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles. (2010) (41)
Anisotropy of the slope of ultrasonic attenuation in formalin fixed human myocardium. (1996) (41)
Anisotropy of the apparent frequency dependence of backscatter in formalin fixed human myocardium. (1997) (40)
Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy (2008) (40)
Molecular Imaging of Human Thrombus with Computed Tomography (2005) (39)
Anti-Angiogenesis Therapy in the Vx2 Rabbit Cancer Model with a Lipase-cleavable Sn 2 Taxane Phospholipid Prodrug using αvβ3-Targeted Theranostic Nanoparticles (2014) (39)
Label-free photoacoustic microscopy of myocardial sheet architecture. (2012) (39)
High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs. (1999) (38)
Quantification of atherosclerotic plaque composition in cholesterol-fed rabbits with 50-MHz acoustic microscopy. (1992) (38)
High-frequency ultrasound detection of the temporal evolution of protein cross linking in myocardial tissue (2000) (38)
Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology. (2002) (38)
Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles. (2013) (37)
A generalized strategy for designing 19F/1H dual‐frequency MRI coil for small animal imaging at 4.7 Tesla (2011) (36)
MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. (2006) (36)
Balanced UTE‐SSFP for 19F MR imaging of complex spectra (2015) (35)
Efficacy of RNA interference knockdown using aerosolized short interfering RNAs bound to nanoparticles in three diverse aphid species (2017) (35)
Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis. (2013) (34)
Cardiomyocyte architectural plasticity in fetal, neonatal, and adult pig hearts delineated with diffusion tensor MRI. (2013) (34)
Application of Renyi entropy for ultrasonic molecular imaging. (2009) (34)
High-frequency ultrasound for quantitative characterization of myocardial edema. (2000) (34)
Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. (2010) (34)
Molecular imaging by MRI (2006) (34)
Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy. (2013) (33)
Experimental determination of phase velocity of perfluorocarbons: Applications to targeted contrast agents (2000) (33)
Cellular Mechanisms of Captopril‐Induced Matrix Remodeling in Syrian Hamster Cardiomyopathy (1994) (33)
Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field (2012) (33)
Nanomedicine Opportunities in Cardiology (2006) (33)
Ultrasonic tissue characterization: integrated backscatter imaging for detecting myocardial structural properties and on-line quantitation of cardiac function. (1994) (33)
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles (2019) (32)
Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures (2010) (32)
Mechanism of the view-dependence of ultrasonic backscatter from normal myocardium (1995) (32)
Vectorcardiographic Quantification of Infarct Size in Baboons (1978) (31)
Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver. (2007) (31)
MR molecular imaging of aortic angiogenesis. (2010) (31)
Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles. (2015) (31)
Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis (2016) (30)
Sensitive detection of abnormal aortic architecture in Marfan syndrome with high-frequency ultrasonic tissue characterization. (1995) (30)
MR angiogenesis imaging with Robo4‐ vs. αVβ3‐targeted nanoparticles in a B16/F10 mouse melanoma model (2010) (30)
Characterization of early neovascular response to acute lung ischemia using simultaneous 19F/1H MR molecular imaging (2013) (30)
Guidelines for credentialing in cardiovascular magnetic resonance (CMR). Society for Cardiovascular Magnetic Resonance (SCMR) Clinical Practice Committee. (2000) (30)
Beyond intravascular imaging: quantitative ultrasonic tissue characterization of vascular pathology (1994) (29)
Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury. (2015) (29)
Cardiac MR imaging: report of a working group sponsored by the National Heart, Lung, and Blood Institute. (1998) (29)
Molecular imaging by cardiovascular MR. (2007) (29)
Correlation Analysis of Stenotic Aortic Valve Flow Patterns Using Phase Contrast MRI (2005) (27)
Nanoparticle Incorporation of Melittin Reduces Sperm and Vaginal Epithelium Cytotoxicity (2014) (27)
New developments in non-invasive cardiac imaging: critical assessment of the clinical role of cardiac magnetic resonance imaging. (1998) (27)
Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear 1H/19F MRI and perfluorocarbon nanoparticles (2014) (27)
Molecular imaging of human thrombus with computed tomography. (2004) (27)
Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery (2015) (27)
Age-related alterations of cardiac tissue microstructure and material properties in Fischer 344 rats. (2001) (26)
Simultaneous Dual Frequency $^{1}{\rm H}$ and $^{19}{\rm F}$ Open Coil Imaging of Arthritic Rabbit Knee at 3T (2011) (26)
Targeted magnetic resonance imaging contrast agents. (2006) (26)
Postformulation peptide drug loading of nanostructures. (2012) (25)
The biologic behavior of balloon hyperinflation-induced arterial lesions in hypercholesterolemic pigs depends on the presence of foam cells. (1995) (25)
Estimation of the elastic stiffness coefficient c13 of fixed tendon and fixed myocardium. (1995) (25)
Quantitative ultrasonic imaging: tissue characterization and instantaneous quantification of cardiac function. (1992) (25)
Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents (2011) (25)
Quantitative ultrasonic characterization of lesion composition and remodeling in atherosclerotic rabbit aorta. (1993) (25)
Applications of RNA interference in the treatment of arthritis. (2019) (25)
Characterization of digital waveforms using thermodynamic analogs: applications to detection of materials defects (2005) (25)
Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug. (2012) (24)
New mechanisms for non-porative ultrasound stimulation of cargo delivery to cell cytosol with targeted perfluorocarbon nanoparticles (2008) (24)
Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts. (2012) (24)
Identification of human myocardial infarction in vitro based on the frequency dependence of ultrasonic backscatter. (1992) (24)
Multicolor computed tomographic molecular imaging with noncrystalline high-metal-density nanobeacons. (2014) (24)
Sensitive Ultrasonic Delineation of Steroid Treatment in Living Dystrophic Mice with Energy-Based and Entropy-Based Radio Frequency Signal Processing (2007) (24)
Contraction-related variation in frequency dependence of acoustic properties of canine myocardium. (1989) (24)
Quantification of ventricular remodeling in the tight-skin mouse cardiomyopathy with acoustic microscopy. (1993) (23)
Rationale for a nanomedicine approach to thrombolytic therapy. (2010) (23)
MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation. (2014) (23)
Angiogenesis imaging with vascular-constrained particles: the why and how (2010) (23)
A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. (2015) (23)
Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy. (2011) (23)
Cardiac cycle-dependent variation of integrated backscatter is not distorted by abnormal myocardial wall motion in human subjects with paradoxical septal motion. (1989) (23)
Quantitative cardiovascular magnetic resonance for molecular imaging (2010) (23)
Ultrasonic tissue characterization of end-stage dilated cardiomyopathy. (1995) (22)
Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent. (2001) (22)
Simultaneous Dual Frequency 1H and 19F Open Coil Imaging of Arthritic Rabbit Knee at 3T (2011) (22)
Molecular Imaging in MR with targeted paramagnetic nanoparticles (2003) (22)
Modifications of natural peptides for nanoparticle and drug design. (2015) (21)
Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent. (2002) (20)
Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling. (2011) (19)
Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice (2018) (19)
Interaction of melittin peptides with perfluorocarbon nanoemulsion particles. (2011) (19)
Angiogenesis and airway reactivity in asthmatic Brown Norway rats (2014) (19)
Can infections be imaged in implanted devices? (2000) (19)
Myocardial tissue characterization (1990) (18)
Delineation of the extracellular determinants of ultrasonic scattering from elastic arteries. (2000) (18)
Anisotropy of ultrasonic backscatter from human tendon compared to that from normal human myocardium (1991) (18)
Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity (2021) (17)
Nanotechnology in interventional cardiology. (2012) (17)
Ultrasonic tissue characterization of blood during stasis and thrombosis with a real‐time linear‐array backscatter imaging system (1993) (17)
Effects of ultraviolet light in vascular cells in vitro and in intact atherosclerotic explants: potential role of apoptosis in vascular biology. (1996) (17)
Self-assembled miRNA-switch nanoparticles target denuded regions and prevent restenosis. (2021) (17)
Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces (2014) (17)
Time-evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent (2000) (17)
Coronary aneurysms in Kawasaki's disease detected by magnetic resonance coronary angiography. (2000) (17)
Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers. (2012) (16)
Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents (1997) (16)
Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis. (2018) (16)
Development of a peptide-siRNA nanocomplex targeting NF- κB for efficient cartilage delivery (2019) (16)
Frequency dependence of acoustic backscatter from 5 to 65 MHz (0.06 < ka < 4.0) of polystyrene beads in agarose. (1996) (15)
Quantification of the anisotropy of ultrasonic quasi-longitudinal velocity in normal human and canine myocardium with comparison to anisotropy of integrated backscatter (1990) (15)
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts (2019) (15)
In vivo diffusion tensor MRI of the mouse retina: a noninvasive visualization of tissue organization (2011) (15)
Quantifying progression and regression of thrombotic risk in experimental atherosclerosis (2015) (15)
Ultrasonic molecular imaging of primordial angiogenic vessels in rabbit and mouse models with /spl alpha//sub v//spl beta//sub 3/ -integrin targeted nanoparticles using information-theoretic signal detection: results at high frequency and in the clinical diagnostic frequency range (2005) (15)
Quantitative characterization of myocardium with ultrasonic imaging. (1988) (15)
Real-time calculation of a limiting form of the Renyi entropy applied to detection of subtle changes in scattering architecture. (2009) (15)
Improved quantitative 19F MR molecular imaging with flip angle calibration and B1‐mapping compensation (2015) (14)
Ultrasonic delineation of aortic microstructure: the relative contribution of elastin and collagen to aortic elasticity. (2004) (14)
Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy (2018) (14)
The effect of frequency on the magnitude of cyclic variation of backscatter in dogs and implications for prompt detection of acute myocardial ischemia (1991) (14)
Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness (2019) (13)
Characterization of digital waveforms using thermodynamic analogs: detection of contrast targeted tissue in mda 435 tumors implanted in athymic mice (2005) (13)
In vivo ultrasonic detection of angiogenesis with site-targeted nanoparticle contrast agents using measure-theoretic signal receivers (2004) (13)
Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles (2012) (13)
Induction of WNT16 via Peptide-mRNA Nanoparticle-Based Delivery Maintains Cartilage Homeostasis (2020) (13)
Joint entropy of continuously differentiable ultrasonic waveforms. (2013) (13)
Backscatter imaging and myocardial tissue characterization (1998) (13)
Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent. (2000) (13)
Photoreceptor degeneration changes magnetic resonance imaging features in a mouse model of retinitis pigmentosa (2011) (12)
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model. (2016) (12)
The FASEB JournalResearch Communication 19 F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons (2007) (12)
Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a “relaxation switch” for detecting cellular endosomal activation (2011) (12)
Quantification of intimal and medial thickness of human coronary arteries by acoustic microscopy (1990) (12)
Targeted inhibition of thrombin attenuates murine neonatal necrotizing enterocolitis (2020) (12)
Cholesterol feeding modulates spatial expression of TGF-β1 and β2 in aortas of Watanabe rabbits (1995) (12)
Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity (2006) (12)
Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models. (2016) (11)
A nanoscale Ti∕GaAs metal-semiconductor hybrid sensor for room temperature light detection. (2010) (11)
Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow‐enhanced‐saturation‐recovery sequence (2013) (11)
Division of labor in honey bees is associated with transcriptional regulatory plasticity in the brain (2019) (10)
Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model. (2010) (10)
Evaluation of liquid perfluorocarbon nanoparticles as a blood pool contrast agent utilizing power Doppler harmonic imaging (2000) (10)
Dual Resolution Simultaneous 19 F / 1 H In Vivo Imaging of Targeted Nanoparticles (2008) (10)
MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles. (2010) (10)
Tesla Magnetic Resonance Imaging-targeted Nanoparticle and 1 . 53 βνα Tumors Using a Novel Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Updated (2003) (9)
Characterization of aortic microstructure with ultrasound: implications for mechanisms of aortic function and dissection (2002) (9)
19 F/ 1 H Simultaneous 3D Radial Imaging of Atherosclerotic Rabbits Using Self-Navigated Respiratory Motion Compensation (2009) (9)
Quantitative intravascular ultrasound. Demonstration using a novel site targeted acoustic contrast agent (1995) (9)
Ultrasonic tissue characterization: prospects for clinical cardiology. (1989) (9)
Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers. (2015) (9)
Improved signal processing to detect cancer by ultrasonic molecular imaging of targeted nanoparticles. (2011) (8)
Application of a real-time, calculable limiting form of the Renyi entropy for molecular imaging of tumors (2010) (8)
Noninvasive detection of transplant coronary artery disease with contrast-enhanced cardiac MRI in pediatric cardiac transplants. (2012) (8)
Oxygenation of the cerebral and coronary circulation with right axillary artery perfusion during venoarterial bypass in primates. (1977) (8)
Entropy vs. Energy Waveform Processing: A Comparison Based on the Heat Equation (2015) (7)
Use of smoothing splines for analysis of backscattered ultrasonic waveforms: Application to monitoring of steroid treatment of dystrophic mice (2011) (7)
Myocardial tissue characterization: clinical confirmation of laboratory results (1989) (7)
Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure. (2020) (7)
Unexpected anisotropic behavior of ultrasound attenuation after collagen cross-linking in porcine tendons (2001) (7)
Chronological age modifies the microscopic remodeling process in viable cardiac tissue after infarction. (2003) (7)
In Vivo 3D 19 F Fast Spectroscopic Imaging (F-uTSI) of Angiogenesis on Vx-2 Tumors in Rabbits Using Targeted Perfluorocarbon Emulsions (2010) (7)
Plaque characterization: surrogate markers or the real thing? (2004) (7)
Intra-articular silencing of periostin via nanoparticle-based siRNA ameliorates post-traumatic osteoarthritis in mice. (2021) (7)
Clinical utility of rapid prescreening magnetic resonance angiography of peripheral vascular disease prior to cardiac catheterization. (2004) (7)
1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles (2004) (6)
Development of a novel site-targeted ultrasonic contrast agent (1997) (6)
Bicuspid Pulmonic Valve and Pulmonary Artery Aneurysm (2014) (6)
Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model (2018) (6)
NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis (2020) (6)
Renal NOXA1/NOX1 Signaling Regulates Epithelial Sodium Channel and Sodium Retention in Angiotensin II-induced Hypertension. (2021) (5)
Application of a limiting form of the Rényi entropy for molecular imaging of tumors using a clinically relevant protocol (2010) (5)
Prospective multicenter clinical trial of surgical pulmonary vein isolation for the treatment of atrial fibrillation (2003) (5)
Magnetic Resonance Imaging of the Cardiovascular System (1999) (4)
A semi-automated algorithm for quantification of vessel wall angiogenesis associated with early atherosclerosis using magnetic resonance imaging (2003) (4)
Multi-resolution simultaneous 19F/1H 3D radial imaging for self-navigated respiratory motion-corrected and quantitative imaging (2010) (4)
Application of Renyi Entropy to Detect Subtle Changes in Scattering Architecture (2008) (4)
Sustained local inhibition of thrombin preserves renal microarchitecture and function after onset of acute kidney injury. (2021) (4)
Fluorine (19F) MRI to Measure Renal Oxygen Tension and Blood Volume: Experimental Protocol. (2021) (4)
Nanotechnologies for Cellular and Molecular Imaging by MRI (2005) (4)
Kinetics of a novel blood pool agent (MP-2269) with persistent high relaxivity for MR angiography. (1998) (4)
Real-time calculation of a limiting form of the Renyi entropy for detection of subtle changes in scattering architecture (2009) (4)
In Vivo quantitative imaging of angiogenesis-targeted PFOB nanoparticles in a hypercholesterol rabbit model using 19F-MRI with ultra-short echo time balanced SSFP (2012) (4)
Application of Real-Time Calculation of a Limiting Form of the Renyi Entropy for Molecular Imaging of Tumors (2010) (4)
Hadamard-type Pulse-Phase Encoding for Imaging of Multi-resonant Fluorine-19 Nanoparticles in Targeted Molecular MRI (2009) (3)
Ultrasonic characterization of backscatter from human cancellous bone with a renyi entopy metric: Correlation with x-ray bone mineral density (2009) (3)
Enhancement of ultrasound reflectivity depends on the specific perfluorocarbons utilized to formulate nanoparticle emulsion contrast agents (2000) (3)
Cholesterol feeding modulates spatial expression of TGF-beta 1 and beta 2 in aortas of Watanabe rabbits. (1995) (3)
Molecular imaging and therapy : New paradigms for 21st century medicine (2006) (3)
Photonic Crystal Nanobeam Cavities (2012) (3)
Angiotensin II Receptor Blockade in Syrian Hamster (T0-2) Cardiomyopathy Does Not Affect Microscopic Cardiac Material Properties: Implications for Mechanisms of Tissue Remodeling (1997) (3)
Precision delivery of RAS-inhibiting siRNA to pancreatic cancer via peptide-based nanoparticles. (2017) (3)
101. Serial Quantification of Targeted Fumagillin Therapy Using avb3-Targeted Paramagnetic Nanoparticles in Early Atherosclerosis at 1.5 T (2005) (3)
Ultra-short Echo Time 19 F / 1 H Imaging of Gadolinium-free Perfluorocarbon Nanoparticles : A Robust Method for In Vivo Angiogenesis Imaging (2010) (3)
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma (2021) (3)
In Situ Localization of Tissue-Factor Following Carotid Angioplasty Using a Ligand-Targeted Ultrasonic Contrast Agent and Intravascular Ultrasound (1998) (3)
Program Director's Page: “It was the best of times, it was the worst of times” (Charles Dickens) (1999) (3)
Molecular imaging with targeted ultrasound contrast agents (2000) (3)
Characterization of cardiovascular tissue with ultrasonic backscatter. (1992) (3)
Augmented and selective delivery of liquid perfluorocarbon nanoparticles to melanoma cells with noncavitational ultrasound (2003) (3)
Nanotherapy Targeting NF-κB Attenuates Acute Pain After Joint Injury. (2019) (3)
Shannon entropy can detect myocardial anisotropy without specular echo gating in vitro. (2009) (3)
Molecular Imaging with Spectral CT Nanoprobes (2017) (3)
Coronary Artery Diameter Determination from Contrast Enhanced MR Angiography ; Comparison with Selective X-ray Contrast Angiography (3)
Targeted nanoparticle imaging of angiogenic endothelial activation in premalignant neoplasia and established epithelial cancers (2006) (3)
Characterization and biodistribution of a novel MRI molecular imaging agent by neutron activation analysis (2005) (3)
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With (cid:1) v (cid:2) 3 -Integrin–Targeted Nanoparticles (2003) (3)
Nanoparticles for Magnetic Resonance Imaging of Tumors (2007) (2)
Amelioration of Posttraumatic Osteoarthritis in Mice Using Intraarticular Silencing of Periostin via Nanoparticle‐Based Small Interfering RNA (2021) (2)
P3100Anti-thrombin nanoparticles limit ischemia-reperfusion injury and no-reflow in myocardial infarction (2019) (2)
Molecular MR Imaging with Paramagnetic Perfluorocarbon Nanoparticles (2008) (2)
Anti-KRAS siRNA nanoparticles for targeted colorectal cancer therapy. (2017) (2)
Ultrasonic molecular imaging of primordial angiogenic vessels in the papilloma virus transgenic mouse with αvβ3-integrin targeted nanoparticles using Renyi entropy-based signal detection (2008) (2)
Magnetic Resonance Molecular Imaging and Targeted Therapeutics (2008) (2)
Advances in ultrasound methods for high-resolution imaging of the cardiovascular system. (1997) (2)
Ultrasonic Imaging and Quantitative Nondestructive Evaluation of the Hearts of Patients (1995) (2)
Waveform processing using entropy instead of energy: A quantitative comparison based on the heat equation (2014) (2)
Single cell sequencing unveils endothelial alterations after cisplatin treatment (2022) (2)
Fast Imaging of Cardiac Strain Using Partial k-Space HARP in Mice (2002) (2)
Perfluorocarbon Nanoparticles for Molecular Imaging and Targeted Therapeutics : These particles allow very sensitive detection of the development of conditions such as cancer and heart disease and can be used to diagnose, treat and monitor therapy (2008) (2)
Multimodality Biomolecular Imaging (2008) (2)
Lymph Nodes for Tumor Metastasis Exosomes Released by Melanoma Cells Prepare Sentinel (2011) (2)
Evaluating Endothelial Damage in Acute Kidney Injury with Perfluorocarbon ( PFC ) Nanoparticles ( NP ) and 19 F MRI (2011) (2)
Apoptosis in human abdominal aortic aneurysms is associated with increased expression of p53 (1996) (2)
Atherosclerosis endothelial activation quantification in vivo with fluorine magnetic resonance imaging and spectroscopy (2014) (2)
The role of proteoglycan (versican) cleavage by the metalioenzyme matrilysin in unstable atherosclerotic lesions in patients (1996) (2)
Diagnostic Value of the Electrocardiogram During Cardiac MRI Stress Testing (2000) (2)
Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury (2022) (2)
Fibrin-targeted thrombolytic therapy using acoustically reflective perfluorocarbon nanoparticles (2005) (2)
From In Vivo Ultrasound and MRI Imaging to Therapy: Contrast Agents Based on Target-Specific Nanoparticles (2010) (2)
Captopril therapy limits ventricular remodeling but does not alter myocardial collagen fiber morphology of cardiomyopathic hamsters. (1997) (2)
2115 A novel targeted iron oxide nanocolloid agent for rapid detection of fibrin clots via T1 and T2 weighted MRI (2008) (2)
Report from the First International Conjoint Conference on Cardiovascular Magnetic Resonance and Echocardiography. (2003) (2)
Molecular imaging using a site-targeted ultrasound contrast agent (1999) (2)
Abstract 2798: Fibrin-specific Spectral CT Molecular imaging Detects Ruptured Plaque without Calcium Interference (2008) (2)
Mdx mice have a defect in autophagy that is restored by rapamycin‐loaded nanoparticle treatment (2012) (2)
Target-binding of PerfluoroCarbon Nanoparticles alters Optimal Imaging Parameters using F-19 Molecular MRI : A Study using fast in vitro Screening and in vivo Tumor Models (2009) (2)
P3C-2 Ultrasound Energy Rapidly Labels Stem/Progenitor Cells with Nanoparticle Beacons without Disrupting Membrane Integrity (2007) (2)
Left Ventricular Contractility is Impaired Following Myocardial Infarction in the Pig and Rat: Assessment by the End Systolic Pressure–Volume Relation Using a Single-Beat Estimation Technique and Cine Magnetic Resonance Imaging (2000) (2)
Noncavitational mechanisms of interaction of ultrasound with targeted perfluorocarbon nanoparticles: implications for drug delivery (2005) (2)
Abstract 18741: Spectral CT Imaging of Coronary Ruptured Plaque: A Step Closer to the Clinic (2010) (1)
Quantification of ultrasonic anisotropy of scattering from myocardium in vitro and in vivo (1992) (1)
Abstract 15949: Bivalirudin Nanoparticles Enable Simultaneous Detection and Potent Inhibition of Acute Clotting (2011) (1)
MR Angiogenesis Imaging with Robo4‐ versus αVβ3‐ Targeted Nanoparticles in the B16/F10 Mouse Melanoma Model (2010) (1)
Abstract 20869: Preservation of Transplant Organ Function and Recipient Survival With Thrombin-Targeted Perfluorocarbon Nanoparticles Perfused Ex Vivo (2016) (1)
PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting (2012) (1)
Abstract 18638: Quantification of Endothelial Activation in Atherosclerosis in vivo With Fluorine Magnetic Resonance Imaging and Spectroscopy (2010) (1)
Abstract 9821: Calcium-Dependent Changes in Myocardial Sheet Mechanics Reveal Reversible Diastolic Dysfunction in Aged Duchenne Muscular Dystrophy (mdx) Mice (2011) (1)
Anti‐thrombotic and Anti‐inflammatory Nanoparticle Limits Early Remodeling in Acute Myocardial Infarction (2019) (1)
Characterization and biodistribution of a novel MRI molecular imaging agent by neutron activation analysis (2005) (1)
DIFFERENT TEMPORAL AND SPATIAL DISTRIBUTION OF TGF-β1 AND TGF-β2 IN RABBIT VASCULAR TISSUE: POTENTIAL ROLE IN NORMAL VESSEL GROWTH AND MATURATION (1996) (1)
Abstract 6152: Molecular Imaging for Early Detection of Inflammation in Valve Disease (2008) (1)
Macrophage pro‐angiogenic miRNA, miR‐27b, is under NF‐kB transcription regulation (2012) (1)
Abstracts (2008) (1)
Perfluorocarbon nanoparticles: A theranostic platform technology (2012) (1)
Quantitative ultrasonic imaging for tissue characterization (1993) (1)
Resolution of Murine Toxic Hepatic Injury Quantified With Ultrasound Entropy Metrics. (2019) (1)
Precision cancer therapy through nanoparticle delivery of siRNA against KRAS. (2016) (1)
Photoacoustic microscopy of myocardial sheet architecture in unfixed and unstained mammalian hearts (2012) (1)
High sensitivity imaging of resin-rich regions in graphite/epoxy laminates using joint entropy (2014) (1)
Quantitative molecular imaging of angiogenesis-targeted fluorinated nanoparticles: new approaches for B1-mapping compensation for 19F-MRI (2013) (1)
In Vivo Quantification of 19 F Molecluar Imaging Agents with improved Accuracy and Sensitivity using Motion Correcting (2008) (1)
Optimal smoothing splines improve efficiency of entropy imaging for detection of therapeutic benefit in muscular dystrophy (2014) (1)
[Recent developments in non-invasive heart imaging. Critical evaluation of the use of cardiac magnetic resonance tomography--results of an interdisciplinary workshop]. (1998) (1)
Fluidic measurement of electric field sensitivity of Ti-GaAs Schottky junction gated field effect biosensors (2010) (1)
Abstract 1162: avb3-Integrin-targeted Paramagnetic Nanoparticles Deliver Rapamycin into the Vascular Wall and Inhibit Stenosis Following Balloon Injury (2006) (1)
Chapter 2 Advanced Detection Techniques and Hardware: Simultaneous19F/1 H MRI (2016) (1)
Thrombus-specific manganese-based “nanobialys” for MR molecular imaging of ruptured plaque (2012) (1)
Thrombin-Absorbing Perfluorocarbon Nanoparticles for Treatment and 19 F Tracking of Acute Thrombosis (2009) (1)
PHOTOACOUSTIC TOMOGRAPHY DIFFERENTIATES EARLY VULNERABLE NEOANGIOGENESIS FROM MATURE VASCULATURE IN VIVO (2011) (1)
First experience with noncavitational ultrasound enhancement of selective cellular delivery of liquid perfluorocarbon nanoparticles to Angiogenic sites (2003) (1)
Thrombin‐inhibiting liposomes as a targeted therapeutic for the treatment of acute thrombosis (2013) (1)
Comparison of ultrasound scattering behavior of Optison/sup /spl reg// and a liquid perfluorocarbon nanoparticle contrast agent (2002) (1)
110 Myofiber developmental plasticity in fetal hearts delineated with diffusion tensor MRI (2008) (1)
Rapid in vivo quantification of oxygen concentration in blood flow with a fluorine nanoparticle reporter and a novel blood enhanced saturation recovery (BESR) sequence (2010) (1)
Comparison of ultrasound scattering properties of Optison(R) with a liquid perfluorocarbon nanoparticle contrast agent (2001) (1)
In vitro acoustic molecular imaging of tissue factor expressed by smooth muscle cells with stable liquid perfluorocarbon nanoparticle contrast agents (2004) (1)
Magnetic resonance imaging and quantification of targeted drug delivery to vascular cells with paramagnetic perfluorocarbon nanoparticles (2002) (1)
Comparison of HARP MRI Tagging Analysis and Manual Approach for Quantification of Left Ventricular Strain in Rats after Myocardial Infarction (2003) (1)
Targeted Nanoparticles for Molecular Imaging and Therapy (2006) (1)
6C-6 Qualitative Properties of an Entropy-Based Signal Detector (2007) (1)
1K-4 Differentiation of Dystrophic and Normal Skeletal Muscle Tissues with Energy and Entropy Images Acquired In Vivo from the Biceps of mdx and Wild-Type Mice (2006) (1)
Abstract 14285: Rapamycin Nanoparticles Potently Induce Cardiac Autophagy and Improve Ventricular Function in 18-month Old mdx Mice, The Animal Model of Duchenne Muscular Dystrophy (2013) (1)
LIVE DEMONSTRATION OF ECHOCARDIOGRAPHY (1997) (1)
Augmented and selective delivery of liquid perfluorocarbon nanoparticles to melanoma cells with ultrasound (2005) (1)
A novel nanoparticle platform, p5RHH-siAXL, inhibits metastasis in gynecologic serous cancers (2018) (1)
Virtual Transducer Color Flow MRI of Septal Defects and Valvular Disease (1991) (1)
Novel anti-inflammatory nanotherapy targeting NF-κB suppresses post-traumatic osteoarthritis (2016) (1)
Further studies on the significance of microaggregates in stored blood. (1975) (1)
Shannon entropy: A specular echo-insensitive imaging metric showing myocardial anisotropy (2009) (1)
Different temporal and spatial distribution of TGF-beta 1 and TGF-beta 2 in rabbit vascular tissue: potential role in normal vessel growth and maturation. (1996) (1)
Diabetes and Cardiovascular Disease aradoxical Increase in Ventricular orsion and Systolic Torsion Rate in Type I iabetic Patients Under Tight Glycemic Control (2016) (0)
CMR2009: 9.04: Multicolored (spectral) CT molecular imaging: the next step in CT imaging (2009) (0)
uantification of Stenotic Mitral Valve rea With Magnetic Resonance Imaging nd Comparison With Doppler Ultrasound hiow (2016) (0)
Radiofrequency Ablation: A Feasibility Study in Animals Successful Performance of Cox-Maze Procedure on Beating Heart Using Bipolar (2013) (0)
Anti-thrombin nanoparticles improve kidney reperfusion and protect kidney function after (2015) (0)
Abstract 589: Quantitative Molecular Imaging of Atherosclerotic Aortic Endothelial Dysfunction With Perfluorocarbon (19F) Nanoparticle Magnetic Resonance Imaging and Spectroscopy (2009) (0)
Development of a site targeted acoustic contrast agent for improved medical ultrasonic diagnosis (1996) (0)
Abstract 141: Anti-thrombin Perfluorocarbon Nanoparticles Decrease Clot Burden in a Murine Model of Venous Thrombosis (2016) (0)
P944Heterogeneity of microvascular damage and barrier disruption in cardiac ischemia-reperfusion injury mapped with perfusable nanoparticles (2018) (0)
Abstract LB-060: A novel target for genetic silencing of AXL mediates taxane resistance, invasion, and migration in uterine cancer (2016) (0)
Sensitive detection of the effects of aging in senescent rat myocardium with ultrasonic tissue characterization (1998) (0)
Abstract 15205: Enhancing Effective Drug Delivery in Cardiac Ischemia Reperfusion Injury With Semipermeable Nanoparticles (2018) (0)
Abstract 1324: Endothelial Stem Cell Detection in vivo with Unique Perfluorocarbon Nanoparticle Labels Using Fluorine (19F) MRI at 1.5 T (2006) (0)
Ultrasonic tissue characterization of remodeling in left ventricular hypertrophy (1995) (0)
Regulation of vascular endothelial signaling with therapeutic nanoparticles that target the NF‐κB pathway (2010) (0)
Regional expression of myocardial sheet dysfunction in dystrophin-deficient cardiomyopathy elucidated with diffusion tensor MRI and optical calcium mapping (2012) (0)
Abstract 5765: 3T MRI Molecular Imaging of Benfluorex Treatment of Metabolic Syndrome with {alpha}v{beta}3-Integrin Targeted Nanoparticles (2008) (0)
Characterization of early neovascular response to acute lung ischemia using simultaneous 19F/1H MR molecular imaging (2013) (0)
Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI (2012) (0)
Abstract 11328: Non-invasive Evaluation of Regional Kidney Oxygen Tension (PO2) with Circulating Perfluorocarbon (PFC) Nanoparticles (NP) and 19F MRI (2011) (0)
Ultrasonic tissue characterization defines the specific role of elastin in maintaining aortic structural integrity and compliance (2003) (0)
P5RHH-siAXL nanoparticle is a novel targeted therapy in metastatic gynecologic serous cancers (2017) (0)
Site-targeted acoustic contrast agent detects molecular expression of tissue factor after balloon angioplasty (2000) (0)
P702Anti-thrombin nanoparticles for reduce vascular damage and promote functional recovery in acute ischemic kidney injury well after reperfusion (2019) (0)
Can infections be imaged in implanted devices? : Infection (2000) (0)
Abstract 16389: Molecular Imaging of Vulnerable Plaque With Thrombus-Specific NanoQ Copper Nanocolloids (2011) (0)
Delineation of Microscopic Cardiac Tissue Remodeling in Cardiomyopathic Syrian Hamster with Diffusion Tensor MRI (2003) (0)
Post‐formulation of peptide‐nanostructures for metered control of NF‐kB signaling (2011) (0)
Zbtb46 coordinates angiogenesis and immunity to control tumor outcome (2023) (0)
CLINICAL IMPLEMENTATION OF ULTRASONIC QUANTITATIVE NONDESTRUCTIVE EVALUATION OF THE HEART: A REVIEW (1998) (0)
Renal Inflammation in Response to Cholesterol Feeding in the ApoE Deficient Mouse Detected In Vivo by Molecular Nanobeacons Targeted to VCAM‐1 (2008) (0)
Improving T 1-Weighted " Hot Spot " Imaging with Colloidal Iron Oxide Nanoparticles (2009) (0)
Abstract 333: Thrombus-specific Manganese Nanocolloids for MR Molecular Imaging of Ruptured Plaque (2009) (0)
Atherosclerosis Imaging with Nanoparticles (2007) (0)
Focal Inhibition of Thrombin Signaling With Anti‐Thrombin Nanoparticles Reduces Ischemia‐Reperfusion Injury in Acute Myocardial Infarction (2018) (0)
New Approach in Characterize siRNA Delivery Platform for Clinical Translation (2018) (0)
Molecular imaging and therapy with perfluorocarbon‐based site targeted contrast nanoparticles (2006) (0)
Bivalirudin Emulsions Demonstrate Efficacy of a Nanoparticle Strategy for Inhibition and Imaging of Thrombosis (2012) (0)
Delineation of relative systolic and diastolic components of congestive heart failure in patients (1998) (0)
The Irons in Your Fire : Iron Oxide Particles & Paramagnetic Nanoparticles (2012) (0)
Ultrasonic Characterization of the Myocardium (2005) (0)
Abstract 606: Antithrombin Nanoparticle Therapy Safely Restores Endothelial Barrier Integrity and Reduces Vessel Hypercoagulability in Atherosclerotic Mice (2015) (0)
3D molecular imaging of the “angiogenic switch” differentiates neovascular development in animal models of cancer (2008) (0)
Multifunctional nanoparticles for detection, quantification, and treatment of endothelial erosions in experimental atherosclerosis (2013) (0)
938-59 Ultrasound Biopsy: A Novel Technique for Nondestructive Intracardiac Tissue Characterization (1995) (0)
Nanoparticle‐Bound Cytolytic Peptide Prodrugs for Cancer Therapy (2015) (0)
Simultaneous Inhibition of Thrombosis and Inflammation Is Beneficial in Treating Acute Myocardial Infarction (2023) (0)
High contrast ultrasonic imaging of resin-rich regions in graphite/epoxy composites using entropy (2016) (0)
Application of a platform nanotechnology for anti‐NF‐kB siRNA delivery to metastatic melanoma (2015) (0)
Affinity-Targeted Contrast Agents (2001) (0)
Detection and quantification of endothelial VCAM‐1 expression using 19F magnetic resonance spectroscopy and imaging (2008) (0)
Ultrasound energy markedly and rapidly effects stem/progenitor cell labeling with nanoparticle beacons for molecular imaging and cell tracking (2007) (0)
Novel approach for specific delivery of cytolytic peptides (melittin) to cancer cells using molecularly targeted perfluorocarbon nanoparticles (2007) (0)
Abstract 15088: Anti-Thrombin Nanoparticles Minimize Kidney Ischemia-Reperfusion Injury by Reducing Inflammation and Preserving Vascular Integrity (2019) (0)
Thrombin inhibitor perfluorocarbon nanoparticles for treatment and 19F tracking of acute thrombosis (2010) (0)
CMR 2005: 4.02: Targeted MR nanoparticles for local anti‐restenotic therapy following angioplasty (2006) (0)
Using liquid fluorocarbon emulsions comprising lipid encapsulated for diagnostic procedures directed in vivo. (1996) (0)
Diffusion MRI of Choroid Melanoma Tumor in Mouse Eye (2008) (0)
PERFLUOROCARBON NANOPARTICLES: TRANSLATING BENCH OPPORTUNITIES TO THE CLINIC (2013) (0)
Abstract 20216: In vivo Mapping of Angiogenesis with Ultralow-Gadolinium Manganese Nanocolloids (2010) (0)
0929 International Session A Novel Site-Targeted Ultrasonic Contrast Agent for Specific Detection of Molecular Ligands (1996) (0)
Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles. (2020) (0)
atherosclerotic rabbit aorta Quantitative ultrasonic characterization of lesion composition and remodeling in (2011) (0)
MRI Studies of Blood-Retina-Barrier Breakdown and ADC in rd1 Mice (2009) (0)
Structural Modifications to Convert Melittin from a Cytolytic Peptide to a Stable Cargo Linker (2010) (0)
Local direct thrombin inhibition preserves renal function by mitigating vascular damage and modulating pathophysiologic processes after onset of acute kidney injury (2021) (0)
Abstract 19752: Nox4 Expression Regulates Inflammation in Tgfβ-treated Vascular Smooth Muscle Cells (2015) (0)
A nanoscale Inverse-Extraordianry Optoconductance (I-EOC) efficient room temperature photodetector (2010) (0)
Vectorcardiographic quantification of infarct size. (1977) (0)
Manganese-Based MRI Contrast Agents: Past, Present, and Future (2012) (0)
Abstract 13445: Thrombin-Inhibiting Nanoparticle Treatment Focally Reduces NF-kB Activation and Tissue Factor Expression in Atherosclerotic Plaques (2015) (0)
Multi-Modality PET-MR Perfluorocarbon Nanoparticle Contrast Agent for Ligand-Targeted Quantitative Imaging (2010) (0)
Minute dosages of (cid:1) (cid:2) (cid:3) 3 -targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits (2008) (0)
Abstract 1492: Molecular Imaging Of Occult Kidney Inflammation In ApoE -/- Mice Using 19F MRI Nanobeacons For VCAM-1 (2008) (0)
Fluorine Magnetic Resonance Assessment of siRNA Delivery to Endothelial Cells via Perfluorocarbon Nanoparticles (2010) (0)
409 Case study: left atria mass evaluation with hyper-enhancement imaging (2008) (0)
Antithrombin Perfluorocarbon Nanoparticle Deposition Prevents Stent Thrombosis (2015) (0)
Abstract 4957: Robust Transfection of Vascular Endothelium for siRNA Knockdown of Vascular Cell Adhesion Molecule-1 Through a Novel Nanoparticle-Lipid Raft Pathway (2009) (0)
Abstract 193: Antithrombin Perfluorocarbon Nanoparticles Ameliorate Renal Injury Following Transient Warm Ischemia (2014) (0)
Abstract 1080: Kras downregulation by nanoparticle delivery of siRNA reduces tumor growth in mice (2016) (0)
Academic and Commercial Nanomedicine (2010) (0)
Dual PARACEST and 19F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles (2009) (0)
Cardiovascular MR function and coronaries: CMR 15 minute express (2013) (0)
4-Aminobutyrate aminotransferase regulates chondrocyte homeostasis and can be targeted using peptide-sirna nanoparticles to attenuate osteoarthritis in a murine injury model (2021) (0)
AXL Knockdown For Therapy of Uterine Cancer (2016) (0)
Assessment Of Myocardial Viability With Analysis Of Ultrasonic Integrated Backscatter (1990) (0)
19F MRS assessment of siRNA delivery to vascular cells via perfluorocarbon nanoparticles (2010) (0)
Entropy imaging and nanostructures (2013) (0)
CMR 2005: 8.02: Fibrin-directed nanoparticles for combined imaging and local thrombolytic therapy (2006) (0)
Molecular Imaging of αvβ3-Integrin: An Opportune Biochemical Signature For Oncologic and Cardiovascular Diseases (2005) (0)
Abstract 2237: Rapid T1w Molecular Imaging of Atherosclerotic Angiogenesis with Colloidal Iron Oxide Nanoparticle (2008) (0)
Focally Acting Thrombin‐Inhibiting Nanoparticles Forestall Atherosclerosis in ApoE‐null Mice (2016) (0)
Abstract 4874: Vascular Endothelial Barrier Compromise in Advanced Atherosclerosis: Novel in vivo Animal Models and Nanoparticle Characterization Methods (2009) (0)
Fibrin-Targeted Thrombolytic Therapy Using Acoustically Reflective Liquid Perfluorocarbon Nanoparticles (2008) (0)
Acoustic Molecular Imaging and Targeted Drug Delivery with Perfluorocarbon Nanoparticles (2005) (0)
P2G-1 Ultrasound Enhances Cellular Lipid Trafficking: Implications for Lipid Therapy (2006) (0)
CMR 2007: 1.02: Potential of streptokinase-activated nanoparticles for early revascularization in acute ischemic stroke (2007) (0)
“Thrombin sponge”: A potent nanoparticle approach to inhibiting coagulation in acute thrombosis (2010) (0)
Abstract 10743: Fluorine MR Angiography for Simultaneous Blood Flow and Oxygen Sensing with Circulating Perfluorocarbon (PFC) Nanoparticles (NP) at 4.7 T (2011) (0)
Nanopackaging of cytolytic peptides (melittin) for cancer therapeutics (2008) (0)
Intramural {alpha}v{beta}3 - Targeted Rapamycine Nanoparticles after Angioplasty Reduces Stenosis Without Delaying Intimal Healing (2007) (0)
Entropy based detection of molecularly targeted nanoparticle ultrasound contrast agents in tumors (2014) (0)
A systematic approach to exosome-based translational (2012) (0)
Copper nanocolloids: a new thrombus molecular imaging approach to ruptured plaque (2012) (0)
Abstract 15963: Ultrastructural Evidence for Plaque Erosions in Hypercholesterolemic Apoe -/- Mice (2016) (0)
Novel tissue factor targeted therapy inhibits vascular smooth muscle cell proliferation (2002) (0)
Abstract 18726: Thrombin-Inhibiting Nanoparticles Prevent Growth of Fibrin Clots by Inhibiting and Adhering to Clot-Bound Thrombin (2013) (0)
Abstract 5580: Nanolytic Approach to Prompt Revascularization in Acute Ischemic Stroke (2009) (0)
Reducing Thrombosis Risk With JNK‐2 siRNA Therapeutic Nanoparticles In ApoE−/− Mice (2016) (0)
Targeted acoustic contrast agents: New opportunities for ultrasound in medical diagnosis and therapy (1998) (0)
Model of Human Hypertrophic Cardiomyopathy Associated With an Increased Upper Limit of Vulnerability in a Transgenic Enhanced Transmural Fiber Rotation and Connexin 43 Heterogeneity (2007) (0)
3D MR neovascular mapping of rabbit Vx2 tumor response to Avastin (bevacizumab) (2008) (0)
Technical advances towards a comprehensive cardiac magnetic resonance examination for diagnosis of coronary artery disease (1998) (0)
Abstract 594: Multicolored (Spectral) CT Molecular Imaging of Ruptured Plaque (2009) (0)
Abstract 2238: New Pharmacokinetic Models for Quantitative Molecular Imaging of Plaque Angiogenesis with Intergrin-targeted Nanoparticles (2008) (0)
Could contrast-enhanced cardiovascular MRI potentially be used to screen pediatric cardiac transplant patients for transplant coronary artery disease? (2012) (0)
Abstract 17074: T1-Weighted MR Imaging of Aortic Angiogenesis in Rabbits with an Ultralow New Low Gadolinium (2011) (0)
Single-input double-tuned birdcage coil with identical B 1 field profile for 1 H and 19 F imaging (2009) (0)
Abstract 4951: A Genetic Model of Vascular Inflammation: Switchable Expression of Hypoxia Inducible Factor1 Alpha (HIF1a) Produces Multistage Targetable Endothelial Activation (2009) (0)
Abstract 10754: Energy-Resolved Computed Tomography for Coronary Fibrin Imaging with New Gold Nanobeacons (2011) (0)
Development of a peptide-siRNA nanocomplex targeting NF- κB for efficient cartilage delivery (2019) (0)
Aging produces marked viscoelastic alterations in viable myocardium (2002) (0)
An application of smoothing splines for molecular imaging of tumors using an improved calculation of a limiting form of Renyi entropy (2010) (0)
775-1 Characterization of Elastin Disruption in Marfan Aortopathy with Frequency Dependent Backscatter (1995) (0)
Age at time of infarction differentially affects the remodeling responses in viable cardiac tissue in young versus old rats (2001) (0)
Using Velocity-Encoded MRI and The Velocity-Time Integral Approach To Analyze the Aortic Valve in Patients with Aortic Stenosis : A Reproducibility Study (2001) (0)
Additional results for "joint entropy of continuously differentiable ultrasonic waveforms" [J. Acoust. Soc. Am. 133(1), 283-300 (2013)]. (2015) (0)
Abstract 3649: Aortic Characterization in Patients with Congenital Bicuspid Aortic Valves Using MR Flow Mapping (2006) (0)
Agents chelateurs a supports lipophiles (2004) (0)
Quantitative molecular imaging of atherosclerotic endothelial dysfunction with perfluorocarbon (19F) nanoparticle magnetic resonance imaging and spectroscopy (2010) (0)
Abstract 5381: VLA-4 targeted nanoparticles deliver a cMYC-MAX prodrug antagonist extends survival a metastatic myeloma mouse model (2014) (0)
Perfluorocarbon nanoparticles: A theranostic technology for MR imaging (2013) (0)
The Role of Thrombosis and Vessel Injury in Acute Myocardial Infarction: Current Standard of Care and Therapeutic Options (2021) (0)
Targeted nanoparticle contrast agents for vascular molecular imaging and therapy (2007) (0)
Molecular imaging and targeted drug delivery: merging medical paradigms (2003) (0)
Protease‐activated peptide toxins for selective nanoparticle therapeutics (1054.4) (2014) (0)
Real‐time Renyi entropy processing for molecular imaging using targeted nanoparticles. (2009) (0)
Multimodality Biomolecular Imaging Guest Editor (0)
Abstract 10285: A Nanomedicine Approach to Restenosis promoting endothelial healing with Targeted Delivery of a New Lipase-labile, Myc-Max Antagonist Prodrug (2011) (0)
Nanotechnology in the diagnosis of atherosclerotic disease. (2008) (0)
Preservation of vasculature is beneficial in mitigating cisplatin induced acute kidney injury (2022) (0)
In vitro exposure of murine macrophages to ultraviolet light induces apoptosis. (1996) (0)
MYOCARDIAL PERFUSION IMAGING WITH AN EXTRAVASCULAR CONTRAST AGENT (1996) (0)
ENHANCED ANTIANGIOGENIC EFFICACY OF PRODRUG NANOPARTICLES QUANTIFIED WITH MAGNETIC RESONANCE IMAGING (2011) (0)
Ultrasonic Tissue Characterization of Myocardial Collagen Crosslinking due to Non-enzymatic Protein Glycosylation (1998) (0)
Abstract 13076: Molecular Imaging of Impaired Angiogenesis in Metabolic Syndrome (2010) (0)
Abstract 15353: JNK2 RNA Silencing Promotes Plaque Healing and Reduces Thrombotic Risk in Atherosclerotic Mice (2016) (0)
Abstract 5760: Early Detection of Arteriopathy in Metabolic Syndrome by MR Molecular Imaging with Targeted Nanobeacons (2008) (0)
AXL, a receptor tyrosine kinase, mediates platinum and taxane resistance in ovarian and uterine cancer (2016) (0)
Comparison of ultrasound scattering behavior of optison and a liquid perflourocarbon nanoparticle contrast agent (2001) (0)
A novel fluorine relaxation switch for tracking the binding and intracellular processing of molecularly targeted nanoparticle contrast agents (2010) (0)
P1273JNK-2 silencing with focally acting peptide-siRNA nanostructures modulates plaque inflammation in atherosclerotic mice (2018) (0)
Age‐Dependent Myocardial Sheet Dysfunction from 3 to 16 months in Duchenne Muscular Dystrophy Mice (mdx) Defined by Diffusion Tensor Magnetic Resonance Imaging (DTI) (2013) (0)
Inverse-extraordianry optoconductance in Ti/Au/GaAs hybrid structures (2011) (0)
Improved paramagnetic chelate for molecular imaging (2005) (0)
Optimization of site-targeted perfluorocarbon nanoparticle contrast in whole blood for molecular imaging applications (2003) (0)
Peptide-siRNA nanotherapeutics in arthritis (2015) (0)
Abstract 2148: Combined Use of avb3-Targeted Nanoparticles and Entropy-Based Signal Detectors for Ultrasound Molecular Imaging of Angiogenesis in the Papilloma Virus Transgenic Mouse (2006) (0)
MR angiogenesis imaging with Robo4- vs. (cid:1) V (cid:2) 3 -targeted nanoparticles in a B16/F10 mouse melanoma model (2011) (0)
Novel ultrasonic contrast agent targeted to D-dimer using DD-3B6 monoclonal F(ab) in vitro (1996) (0)
High-frequency ultrasonic detection of protein crosslinking in myocardial tissue (1998) (0)
Magnetic Resonance Imaging of Uveal Melanoma in Mice (2009) (0)
Noncavitational nonporative ultrasound elicits marked in vivo augmentation of tumor drug delivery with targeted perfluorocarbon nanoparticles (2008) (0)
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts (2019) (0)
Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury (2023) (0)
P4656Thrombin targeted nanoparticles limit ischemia reperfusion injury in acute myocardial infarction (2018) (0)
Is 3D MR molecular imaging of neovasculature prognostic of tumor response to antiangiogenic therapy? (2008) (0)
Abstract 3657: Cell-Specific Delivery and Monitoring of Antiangiogenic Therapy in Experimental Aortic Valve Disease with Theranostic Integrin-Targeted 19F Nanobeacons (2008) (0)
Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image‐Guided Drug Delivery (2011) (0)
Ultra-short Echo Time Balanced SSFP for Highly Sensitive Detection and Quantification of Multi-resonant F Imaging Agents for Targeted Molecular MRI (2010) (0)
Magnetic Resonance Magnetic Resonance Imaging of the Cardiovascular System * (2007) (0)
Abstract 16590: Sensitive, Concentration-dependent Entropy Metrics for Quantitative Ultrasound Molecular Imaging of Thrombi (2016) (0)
Theragnostic Nanoparticles with the Power to Diagnose, Treat and Monitor Diseases (2011) (0)
Quantitative magnetic resonance valve imaging: An accurate tool for evaluating mitral stenosis (2003) (0)
Optimization of 19 F MR quantification of administrated PFC nanoparticle in vivo : mathematical simulation and experimental validation (2009) (0)
CION v2.0: a better way to T1 enhancement with iron oxides (2010) (0)
Angiogenesis and airway reactivity in asthmatic Brown Norway rats (2014) (0)
Monitoring of myocardial edema with quantitative ultrasonic parametric imaging (1999) (0)
Abstract P2-19-02: mTOR Pathway Inhibitor Nanoparticles Beneficially Modulate Autophagy in Triple Negative Breast Cancer Cells (2010) (0)
1K-5 Information Theoretic Ultrasound Imaging Differentiates Dystrophin-Deficient and Normal Skeletal Muscle in Humans (2006) (0)
Diffusion Tensor MRI Detects Photoreceptor Degeneration in Mouse (2008) (0)
Synthetic nanoparticle vehicles deliver siRNA to vascular endothelial cells for VCAM‐1 knockdown (2008) (0)
Biocompatible Peptide‐nanoparticle Constructs for Molecular Imaging and Therapy (2009) (0)
Ultrasound‐mediated nanoparticle drug delivery in an invivo tumor model (2006) (0)
Intramural αvβ3 ‐ Targeted Rapamycine Nanoparticles after Angioplasty Reduces Stenosis Without Delaying Intimal Healing (0)
Is magnetic resonance imaging a reliable tool for quantifying aortic valve stenosis (2002) (0)
1 H / 19 F MRI of Lung Angiogenesis with α v β 3-integrin Targeted Perfluorocarbon Nanoparticles (2011) (0)
Abstract 1727: Ultrasound Detection of Molecular Epitopes Critical For Thrombosis and Restenosis With Tissue Factor-Targeted Perfluorocarbon Nanoparticles (2006) (0)
Diagnostic and Therapeutic Targeted Perfluorocarbon Nanoparticles (2007) (0)
7506 Simultaneous 19 F / 1 H MR Molecular Imaging of Neovascularization in Pulmonary Inflammation (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Samuel a. Wickline?

Samuel a. Wickline is affiliated with the following schools:

Samuel a. Wickline's Academic­Influence.com Rankings

Samuel a. Wickline's Degrees

Why Is Samuel a. Wickline Influential?

Samuel a. Wickline's Published Works

Published Works

What Schools Are Affiliated With Samuel a. Wickline?

Samuel a. Wickline's AcademicInfluence.com Rankings